Priority Date: 27.01.12 (US 201261591299P)
INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING ALPHA-V-BETA-3
- Application ID: EP13701748
- Status: █ PATENT GRANTED
Applicant
Technology Company
Attorney
Specialization
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). F. Hoffmann-La Roche AG is specialized in A61. F. Hoffmann-La Roche AG is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
Timeline
- 27.01.2012 - Priority Date (US 201261591299P)
- 01.08.2013 - Publication A1 (WO2013110578)
- 03.12.2014 - Publication A1 (EP2806899)
- 19.10.2016 - Publication B1 (EP2806899)